Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,891.00p
   
  • Change Today:
      16.00p
  • 52 Week High: 2,205.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 414,106
  • Market Cap: £4,195.85m
  • RiskGrade: 125

Tuesday broker round-up

By Caoimhe Toman

Date: Tuesday 20 Nov 2018

LONDON (ShareCast) - (Sharecast News) - Coats: RBC Capital Markets initiates at outperform with a target price of 110p.
Applegreen: Berenberg reiterates buy with a target price of 600p.

GVC Holdings: Berenberg reiterates buy with a target price of 1,300p.

Homeserve: Liberum reiterates buy with a target price of 1,120p.

Glencore: Deutsche Bank reiterates buy with a target price of 450p.

Genel Energy: JP Morgan overweight with a target price of 290p.

Hikma Pharmaceuticals: JP Morgan reiterates neutral with a target price of 1,900p.

Tullow Oil: JP Morgan reiterates overweight with a target price of 292p.

Bodycote: RBC Capital Markets initiates outperform with a target price of 950p.

IMI: RBC Capital Markets initiates sector perform with a target price of 1,010p.

easyjet: Liberum reiterates hold with a target price of 1,250p.

W resources: Northland Capital Markets reiterates buy with a target price of 1.2p.

Renewi: Kepler Cheuvreux reiterates buy with a target price of 77p.

Eckoh: Canaccord reiterates buy with a target price of 50p.

Compass: Numis reiterates hold with a target price of 1,650p.

Aveva: Numis reiterates buy with a target price of 3,225p.

Royal Mail: Berenberg reiterates sell with a target price of 280p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,891.00p
Change Today 16.00p
% Change 0.85 %
52 Week High 2,205.00p
52 Week Low 1,722.00p
Volume 414,106
Shares Issued 221.89m
Market Cap £4,195.85m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average
1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average
Price Trend
44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 28-Jun-2024

Time Volume / Share Price
16:37 2,829 @ 1,891.00p
16:35 2,539 @ 1,891.00p
16:35 294 @ 1,891.00p
16:35 273,431 @ 1,891.00p
16:35 300 @ 1,891.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page